[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:17-beta-hydroxysteroid-dehydrogenase-xiii":3},{"name":4,"total":5,"recruiting":5,"trials":6},"17-BETA-HYDROXYSTEROID DEHYDROGENASE XIII",1,[7],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT05519475","A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition",[11],"Phase 2","RECRUITING","2026-08-26T02:19:23.493898Z","2026-07-05T05:32:16.802708Z"]